Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mertelsmann

Showing results (341-350 of 366) with videos related to

Pageof 37
Sort By:
Cancer Clinical Trials|January 1, 1981
Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanineZ A Arlin, N Flomenberg, T S Gee, et al.
Blood|August 1, 1988
Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adultsZ A Arlin, E Feldman, S Kempin, et al.
Aktuelle Radiologie|December 31, 1997
[Guidelines for standardized diagnosis, therapy and after-care of thyroid cancer]R Engelhardt, E H Farthmann, N Freudenberg, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1997
Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblastsA Mackensen, H Veelken, M Lahn, et al.
Blood|August 15, 1997
Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patientsA Kiani, A Tschiersch, E Gaboriau, et al.
Clinical Immunology and Immunopathology|February 1, 1984
Autologous and allogeneic mixed-lymphocyte responses following thermal injury in man: the immunomodulatory effects of interleukin 1, interleukin 2, and a prostaglandin inhibitor, WY-18251A C Antonacci, S E Calvano, L E Reaves, et al.
Blood|December 1, 1979
The coexistence of acute myeloblastic leukemia and diffuse histiocytic lymphoma in the same patient as demonstrated by multiparameter analysisD J Straus, M Andreeff, H J Hansen, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Correlation of biochemical and immunological markers with conventional morphology and clinical features in 120 patients with malignant lymphomasR Mertelsmann, D A Filippa, B Koziner, et al.
Cancer Research|March 1, 1985
Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemiaA N Daghestani, Z A Arlin, B Leyland-Jones, et al.
Critical Reviews in Oncology/Hematology|January 1, 1986
Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literatureB D Clarkson, T Gee, Z A Arlin, et al.
Pageof 37

Showing results (341-350 of 366) with videos related to

Sort By:
Pageof 37
Cancer Clinical Trials|January 1, 1981
Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanineZ A Arlin, N Flomenberg, T S Gee, et al.
Blood|August 1, 1988
Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adultsZ A Arlin, E Feldman, S Kempin, et al.
Aktuelle Radiologie|December 31, 1997
[Guidelines for standardized diagnosis, therapy and after-care of thyroid cancer]R Engelhardt, E H Farthmann, N Freudenberg, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1997
Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblastsA Mackensen, H Veelken, M Lahn, et al.
Blood|August 15, 1997
Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patientsA Kiani, A Tschiersch, E Gaboriau, et al.
Clinical Immunology and Immunopathology|February 1, 1984
Autologous and allogeneic mixed-lymphocyte responses following thermal injury in man: the immunomodulatory effects of interleukin 1, interleukin 2, and a prostaglandin inhibitor, WY-18251A C Antonacci, S E Calvano, L E Reaves, et al.
Blood|December 1, 1979
The coexistence of acute myeloblastic leukemia and diffuse histiocytic lymphoma in the same patient as demonstrated by multiparameter analysisD J Straus, M Andreeff, H J Hansen, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Correlation of biochemical and immunological markers with conventional morphology and clinical features in 120 patients with malignant lymphomasR Mertelsmann, D A Filippa, B Koziner, et al.
Cancer Research|March 1, 1985
Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemiaA N Daghestani, Z A Arlin, B Leyland-Jones, et al.
Critical Reviews in Oncology/Hematology|January 1, 1986
Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literatureB D Clarkson, T Gee, Z A Arlin, et al.
Pageof 37